MAIA Biotechnology, Inc. 宣布融资 620 万美元以推进靶向免疫肿瘤学研究

积极 #THIO#Statements#Forward#Biotechnology#clinical trial
来源:www.biospace.com 发表于:2021-10-14
Oct. 14, 2021 12:00 UTC CHICAGO--(BUSINESS WIRE)-- MAIA Biotechnology, Inc., a targeted therapy, immuno-oncology company focused on developing potential first-in-class oncology drugs (“MAIA”)... 原文链接
本文新闻来源www.biospace.com,版权归原作者所有,内容仅代表作者本人观点,不代表企查查的立场。如有任何疑问或需要删除,请联系 kefu@qichacha.com